1. Abstract 1.1. Background Situs inversus totalis (SIT) is a rare congenital anomaly characterized by mirror-image anatomy, posing challenges during endoscopic retrograde cholangiopancreatography (ERCP). Literature on ERCP in SIT is limited to sporadic case reports and small series. We report three cases of ERCP in SIT with emphasis on technical modifications, positioning, safety, and outcomes.
1. Abstract 1.1. Back ground An abdominal aortic aneurysm (AAA) is a weakened and bulging section of the aorta. While most AAAs are asymptomatic until they rupture, which is a life-threatening emergency causing severe pain and internal bleeding, they are often detected through imaging.
1. Abstract 1.1. Introduction Tuberculous lymphadenopathy, though typically presenting with symptoms of tuberculosis, can exceptionally manifest as dysphagia due to esophageal compression or involvement.
1. Abstract 1.1. Introduction Hepatitis B virus (HBV) impacts large number of populations worldwide and has both hepatic and extrahepatic manifestations. It can present as acute hepatitis.
1. Abstract Left-sided gallbladder (LSG) is a rare congenital anomaly where the gallbladder is located to the left of the round ligament. It can occur alone or as part of situs inversus syndrome.
1. Abstract Upper extremity deep venous thrombosis (UEDVT) is a condition characterised by thrombosis in the veins of the upper limb.
Hemophagocytic Lymphohistiocytosis (HLH) is a rare but severe sys temic inflammatory syndrome, often classified under autoimmune conditions. It is characterised by the excessive activation and proliferation of cytotoxic T cells and histiocytes (macrophages), leading to widespread immune dysregulation. There are two types of HLH one is primary and the other is secondary.
1. Abstract Colovesical fistulas (CVFs) are significant complications arising from diverticulitis and colorectal cancer. These fistulas create abnormal connections between the colon and bladder, leading to symptoms like pneumaturia and fecaluria. Given the variability in symptoms,
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.
